- More than 20 years’ experience in leading and managing global biotechnology companies, and working with a number of public, late-stage oncology companies
- Currently, Board member & Audit Committee Chair – Kura Oncology (Nasdaq KURA) and Antibe Therapeutics (TSX ATE); Board member, Chairman of the Board – Kintara Therapeutics (Nasdaq KTRA)
- Previously, served as Chief Financial Officer and Senior Vice President, Finance of Nasdaq-listed Heron Therapeutics (Nasdaq HRTX).
- Other experiences include Executive Vice President and Chief Financial Officer of Innovus Pharmaceuticals and Chief Financial Officer of AnaptysBio
- Part of the founding management team of Arena Pharmaceuticals in 1997 until 2015
- BBA from St. Bonaventure University